Skip to content

Saving 170 Billion USD with Health IT: Infographic About Adherence

I recently worked as a consultant for a pharmaceutical company as they asked me to help them create a long-term digital strategy. In this work, I learnt about some new health IT developments and one of them seemed to be very interesting. It aimed at improving adherence through an online system.

They say the world could save 170 billion USD by using their patform based on survey-evidenced results and the estimated nonadherence-related health expenditures. Here is their brief description:

PraxisPlatform developed a proprietary, versatile, fully secure health care ICT platform on which it designs and manages patient adherence management programmes, pharmacy care programmes and non-interventional clinical studies for innovative and generic pharmaceuticals and medical devices. PraxisPlatform currently reaches 120.000 patients, 4.800 physicians and 100 pharmacies in Hungary.

PraxisPlatform has a proven track record of increasing patients’ adherence to medicinal treatment by 70-130 per cent (at 6/12 months) in chronic therapy areas such as hyperlypidaemia (high cholesterol levels), prostatic hyperplasia and breast cancer.

Here is the infographic they came up with (click on the image for larger size)

I think there are some key conclusions of this:

  • It’s important to develop something that is scalable on many levels.
  • As adherence is a global problem, a locally proven method could work anywhere else.
  • The ICT behind a digital health development must be universal but flexible to local needs.
  • They are also ready to sell the know-how with legal wireframes, not only the service itself.

What do you think about it?

5 Comments Post a comment
  1. Adherence is less of an issue than the companies that stand to benefit (pharmacy benefits managers, for example) are suggesting. For example, there’s the issue of routine formulary changes with “therapeutically equivalent” medicines. If a patient hasn’t switched, might that have something to do with the fact that they have a supply (typically filled in 90-day increments in the U.S.) the old medicine they haven’t yet exhausted? The reality is that nonadherence is less of a problem than it has been depicted.

    January 2, 2014
    • mmark #

      In some countries it is really hard to objectivize the extent of non-adherence, but I hardly believe that we can overemphasize the importance of the issue. In some countries with single insurer model/one sick fund/one prescription database it’s possible to track the persistence of each and every patient of a nation. Hungary is one of these counties and the objective measures concluded to surprisingly poor persistence rates in many chronic therapeutic fields (20-40% on therapy at the end of the first year). These objective calculations take into consideration when the patient will run out of the last supply, and you can run the method for brands, active substances or every “similar” drugs to filter those patients, that really stop the treatment.

      January 3, 2014
  2. BenK #

    There are many different areas of non-compliance; including failed lifestyle changes. Breaking these down to avoid confusion is critically important. Assigning costs to the category is a poor idea; it risks major misattribution.

    This infographic has numerous problems, too many to address here; but some warning flags in the infographic include ‘suboptimal generic use’ and ‘medication errors.’ These suggest that there should be sub-categories and additional explanation.

    There are great opportunities for compliance enhancement simply by reminding people to self-administer, but better yet, there should be systems that allow for dynamic dosing in response to symptoms, real-time postmarketing surveillance in the form of population-level CER/adverse event tracking, and supply chain optimization.

    January 2, 2014
  3. Adherence is a major issue and progress needs to be made in that area. Any assistance is better than none at all. Often patients leave the hospital or doctor’s office with little or no awareness of the risk of skipping or stopping medications. Education and reminders could make a major difference.

    January 17, 2014

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


Get every new post delivered to your Inbox.

Join 61,459 other followers

%d bloggers like this: